Pancreatic Tumors and Immature Immunosuppressive Myeloid Cells in Blood and Spleen: Role of Inhibitory Co-Stimulatory Molecules PDL1 and CTLA4. An In Vivo and In Vitro Study-Reference-Cited by-同舟云学术

Pancreatic Tumors and Immature Immunosuppressive Myeloid Cells in Blood and Spleen: Role of Inhibitory Co-Stimulatory Molecules PDL1 and CTLA4. An In Vivo and In Vitro Study

Published:2013-01-24 Issue:1 Volume:8 Page:e54824
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Basso Daniela,Fogar Paola,Falconi Massimo,Fadi Elisa,Sperti Cosimo,Frasson Chiara,Greco Eliana,Tamburrino Domenico,Teolato Sara,Moz Stefania,Bozzato Dania,Pelloso Michela,Padoan Andrea,De Franchis Giuseppe,Gnatta Elisa,Facco Monica,Zambon Carlo-Federico,Navaglia Filippo,Pasquali Claudio,Basso Giuseppe,Semenzato Gianpietro,Pedrazzoli Sergio,Pederzoli Paolo,Plebani Mario

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference63 articles.

1. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification;G Klöppel;Ann N Y Acad Sci,2004

2. Pancreatic cancer;M Hidalgo;N Engl J Med,2010

3. Hallmarks of cancer: the next generation;D Hanahan;Cell,2011

4. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase;S Hiratsuka;Nat Cell Biol,2008

5. Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N-terminal peptide (NT-S100A8);D Basso;J Cell Physiol,2011

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances of immune-checkpoint inhibition of CTLA-4 in pancreatic cancer;Biomedicine & Pharmacotherapy;2024-10

2. The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promising circulating biomarkers;Journal of Experimental & Clinical Cancer Research;2024-07-18

3. LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study;The Lancet Oncology;2024-04

4. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma;Frontiers in Immunology;2024-02-07

5. Prognostic value of diffuse reduction of spleen density on postoperative survival of pancreatic ductal adenocarcinoma: A retrospective study;Asia-Pacific Journal of Clinical Oncology;2023-02-07